Literature DB >> 21569196

Expression of epidermal growth factor receptor (EGFR) and Ki67 in feline oral squamous cell carcinomas (FOSCC).

G T Bergkvist1, D J Argyle, L Morrison, N MacIntyre, A Hayes, D A Yool.   

Abstract

The aims of this study were to establish expression of epidermal growth factor receptor (EGFR) and Ki67 in 67 archived biopsy samples of feline oral squamous cell carcinomas (FOSCCs) and to establish if the expression of either markers was predictive of survival. Samples were immunohistochemically labelled for the two proteins and scored. Statistical analyses of data, including Kaplan-Meier survival curves, were performed. All samples expressed both markers although levels differed between samples. Median overall survival was 46 days and 1-year survival was 5%. There was no correlation between Ki67 and EGFR scores (Pearson's correlation coefficient, P = 0.861). Low cellular proliferation (low Ki67 score) was positively correlated with an overall longer survival (Log Rank, P = 0.02) and a trend towards better survival for the high EGFR group was observed (Log Rank, P = 0.076). Ki67 and EGFR immunostaining in FOSCC may be of value as biochemical markers for screening of biopsies from cases of FOSCC.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21569196     DOI: 10.1111/j.1476-5829.2010.00239.x

Source DB:  PubMed          Journal:  Vet Comp Oncol        ISSN: 1476-5810            Impact factor:   2.613


  11 in total

1.  Combined zoledronic acid and meloxicam reduced bone loss and tumour growth in an orthotopic mouse model of bone-invasive oral squamous cell carcinoma.

Authors:  C K Martin; W P Dirksen; M M Carlton; L G Lanigan; S P Pillai; J L Werbeck; J K Simmons; B E Hildreth; C A London; R E Toribio; T J Rosol
Journal:  Vet Comp Oncol       Date:  2013-05-08       Impact factor: 2.613

2.  Investigation of immune cell markers in feline oral squamous cell carcinoma.

Authors:  Ellen E Sparger; Brian G Murphy; Farina Mustaffa Kamal; Boaz Arzi; Diane Naydan; Chrisoula T Skouritakis; Darren P Cox; Katherine Skorupski
Journal:  Vet Immunol Immunopathol       Date:  2018-06-13       Impact factor: 2.046

3.  Immunohistochemical quantification of the cobalamin transport protein, cell surface receptor and Ki-67 in naturally occurring canine and feline malignant tumors and in adjacent normal tissues.

Authors:  Annette M Sysel; Victor E Valli; Joseph A Bauer
Journal:  Oncotarget       Date:  2015-02-10

4.  Characterization of STAT3 expression, signaling and inhibition in feline oral squamous cell carcinoma.

Authors:  Megan E Brown; Misty D Bear; Thomas J Rosol; Chris Premanandan; William C Kisseberth; Cheryl A London
Journal:  BMC Vet Res       Date:  2015-08-14       Impact factor: 2.741

5.  Prognostic utility of apoptosis index, Ki-67 and survivin expression in dogs with nasal carcinoma treated with orthovoltage radiation therapy.

Authors:  Dah-Renn Fu; Daiki Kato; Ai Watabe; Yoshifumi Endo; Tsuyoshi Kadosawa
Journal:  J Vet Med Sci       Date:  2014-08-25       Impact factor: 1.267

Review 6.  Cats, Cancer and Comparative Oncology.

Authors:  Claire M Cannon
Journal:  Vet Sci       Date:  2015-06-30

7.  Investigation of novel chemotherapeutics for feline oral squamous cell carcinoma.

Authors:  Hunter John Piegols; Marilia Takada; Maciej Parys; Thomas Dexheimer; Vilma Yuzbasiyan-Gurkan
Journal:  Oncotarget       Date:  2018-09-04

Review 8.  Non-murine models to investigate tumor-immune interactions in head and neck cancer.

Authors:  Carlos Rossa; Nisha J D'Silva
Journal:  Oncogene       Date:  2019-03-14       Impact factor: 9.867

Review 9.  Molecular targets for anticancer therapies in companion animals and humans: what can we learn from each other?

Authors:  Irati Beltrán Hernández; Jannes Z Kromhout; Erik Teske; Wim E Hennink; Sebastiaan A van Nimwegen; Sabrina Oliveira
Journal:  Theranostics       Date:  2021-02-06       Impact factor: 11.556

10.  A naturally occurring feline model of head and neck squamous cell carcinoma.

Authors:  Jackie M Wypij
Journal:  Patholog Res Int       Date:  2013-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.